Adding $5,000 to These 2 Top Stocks Could Make You Richer in 2021 (and Beyond)

According to the U.S. Centers for Disease Control and Prevention (CDC), cancer is the second-leading cause of death in the U.S. (behind heart disease), claiming 599,601 lives in 2019. On the bright side, there has been notable progress in the multi-pronged approach to fight this disease. One area where scientists are making substantial headway is in the field of cancer diagnostics.

This market was valued at $144.4 billion in 2018 and will keep expanding at a compound annual growth rate (CAGR) of 7% through 2026, according to the research firm Grand View Research. Purchasing shares of leading companies within this field could yield juicy returns down the road. Two cancer diagnostics-focused stocks worth buying are Exact Sciences (NASDAQ: EXAS) and Guardant Health (NASDAQ: GH). Here is why an investment of $5,000 in either (or both) of these companies would be a great move.